Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation

Trial Profile

Effects of Inhaled Nitric Oxide on Ischemia-Reperfusion Injury in Human Liver During Transplantation

Completed
Phase of Trial: Phase II/III

Latest Information Update: 28 Apr 2016

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Liver injury; Reperfusion injury
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 May 2014 New trial record
    • 17 Nov 2009
    • 21 Apr 2008
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top